Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine

Name: Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine
Published: 2010
License: Public Domain

Novartis Vaccines · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

prevention vaccination

meningococcal disease, children, pre-school, prevention, vaccination, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine

Related documents